Trials / Terminated
TerminatedNCT02466659
Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
A Clinical Trial of Observation Versus Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 3 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.
Detailed description
Intermittent exotropia (IXT) is the most common form of childhood-onset exotropia with an incidence of 32.1 per 100,000 in children. Before surgery, many cases of IXT are treated using non-surgical interventions, such as part-time alternate occlusion. However, the "alternating" occlusion with traditional patches is usually out of control. The investigators are uncertain about the amount of "alternating" in patching treatment. Here, the investigators introduce controlled intermittent alternating occlusion (CIAO) therapy, which is provided by a new electronic device, -liquid crystal glasses. This study is to determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old. Children with IXT will be randomized into either an observation group or a CIAO therapy group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CIAO therapy Amblyz glasses | 3-hour CIAO Therapy Amblyz glasses |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-06-09
- Last updated
- 2017-11-30
- Results posted
- 2017-11-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02466659. Inclusion in this directory is not an endorsement.